Literature DB >> 3033059

Clearance of hepatitis B surface antigen (HBsAg) after surgical resection of hepatocellular carcinoma.

T T Wu, H C Hsu, D S Chen, J C Sheu, I J Su, S L Chen, S M Chuang.   

Abstract

The serum HBsAg in 4 chronic HBsAg carrier patients with hepatocellular carcinoma (HCC) cleared within 4-38 months after surgical resection of their hepatic tumors. Two patients developed anti-HBs. During the follow-up period from 21 to 28 months after HBsAg clearance, none of the patients regained positive serum HBsAg. Two patients who had had tissue HBsAg present, exclusively in the tumor, showed quick HBsAg clearance after resection. The other 2 patients had a delayed HBsAg clearance. One had tissue HBsAg in both the tumor and nontumoral liver. Only 1 patient had tissue HBsAg in the liver, but not in the tumor. During the same period of observation of 323 chronic HBsAg carriers, who had a variety of histologically-verified chronic liver diseases and were followed for more than 6 months, only 1 cleared the antigen. The spontaneous HBsAg clearance in our HBsAg carriers (1/323) was significantly lower than that (4/64) of HBsAg-positive HCC patients with tumor resection, P less than 0.004. The mechanisms of HBsAg clearance in HCC patients after surgical resection of tumors are discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3033059     DOI: 10.1016/s0168-8278(87)80008-9

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  9 in total

Review 1.  Diagnosis and management of clinical and subclinical cobalamin deficiency: advances and controversies.

Authors:  Ralph Carmel; Mona Sarrai
Journal:  Curr Hematol Rep       Date:  2006-03

Review 2.  Natural history of chronic hepatitis B: phases in a complex relationship.

Authors:  Catherine M N Croagh; John S Lubel
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

3.  Spontaneous hepatitis B surface antigen clearance in a long-term follow-up study of patients with chronic type B hepatitis. Lack of correlation with hepatitis C and D virus superinfection.

Authors:  L C Da Silva; C L Madruga; F J Carrilho; J R Pinho; A Saéz-Alquezar; C Santos; L Bassit; C Barreto; L E Fonseca; V A Alves; R Leitão; R Vianna; R A Cardoso; A V França; L C Gayotto
Journal:  J Gastroenterol       Date:  1996-10       Impact factor: 7.527

4.  KASL clinical practice guidelines for management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2022-04-01

5.  HBsAg seroclearance in Chinese patients receiving lamivudine therapy for chronic hepatitis B virus infection.

Authors:  Man-Fung Yuen; Danny Ka-Ho Wong; He-Jun Yuan; Siu-Man Sum; Ching-Lung Lai
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

6.  Ethnic differences in incidence of hepatitis B surface antigen seroclearance in a real-life multicenter clinical cohort of 4737 patients with chronic hepatitis B infection.

Authors:  L H Nguyen; J Hoang; N H Nguyen; V D Vu; C Wang; H N Trinh; J Li; J Q Zhang; M H Nguyen
Journal:  Aliment Pharmacol Ther       Date:  2016-07-01       Impact factor: 8.171

7.  The histopathology of the liver in older patients with hepatitis B virus surface antigenaemia.

Authors:  H Sugimura; T Fukazawa; M Saitoh; K Nakamura; H Shimada; K Ohtsubo
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

8.  Clinical outcomes of delayed clearance of serum HBsAG in patients with chronic HBV infection.

Authors:  Soon Woo Nam; Jeong Jo Jung; Si Hyun Bae; Jong Young Choi; Seung Kew Yoon; Se Hyun Cho; Joon Yeol Han; Nam Ik Han; Jin Mo Yang; Young Suk Lee
Journal:  Korean J Intern Med       Date:  2007-06       Impact factor: 2.884

9.  Spontaneous Hepatitis B Seroclearance upon Development of Hepatocellular Carcinoma.

Authors:  Sara Naimimohasses; Omar El Sherif; Mohammad Ashfaq; Niamh Nolan; Masood Iqbal; Susan McKiernan; Suzanne Norris
Journal:  Case Rep Gastroenterol       Date:  2017-12-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.